Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05060341 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since May 19, 2025, no change to tracked fieldsv5-v6
  2. Trial status: Enrolling by Invitation to Active, Not Recruitingv4 Show 5 more changesShow less
    • Enrollment target: estimated 24 to confirmed 22
    • Primary completion date: Nov 2026 to Mar 2027
    • Study completion date: Nov 2027 to Mar 2027
    • Study description shortened, about 1 word
    • Study title shortened, about 2 words
  3. Re-verified, no change to tracked fieldsv3
  4. Lead sponsor: MeiraGTx UK II Ltd to MeiraGTx, LLCv2 Show 4 more changesShow less
    • Enrollment target: 30 to 24
    • Study sites: 5 to 4
    • Study description shortened, about 7 words
    • Eligibility criteria expanded, about 2 words
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
MeiraGTx, LLC
5 trials monitored
See 1 trial at risk
This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia
Trial Details
NCT Number NCT05060341
Lead Sponsor MeiraGTx, LLC
Conditions
(from sponsor)		 Radiation-induced Xerostomia
Enrollment 22 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov